Endocrine oncology

Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence

J Clin Endocrinol MetabPublished Retrospective cohort study

Main finding · RecurrenceResult — go to the resultHazard ratio 2.96 95% CI 1.28–6.87

Authors' conclusion

Low mitotic activity is relatively common in PTC and its behavior lies within a spectrum between no and high mitotic activity. Given its association with aggressive clinicopathologic features and recurrence, low mitotic activity should be considered when risk stratifying patients with PTC for recurrence.

Study context

Population
Consecutive patients with papillary thyroid cancer (PTC) at a single institution, 2018–2022
Participants
640 PTCs
Exposure
Low vs no and high mitotic activity in PTC
  • No mitotic activityn = 515reference
  • Low mitotic activityn = 110
  • High mitotic activityn = 15
Outcome
Recurrence
Methodological detailssingle-institution, consecutive series
  • Single-institution
  • Consecutive series

Main finding

As reported in the abstract

Hazard ratio

2.96

95% CI 1.28–6.87

P = 0.01

By group

Low mitotic activityvs No mitotic activity
HR 2.96 (95% CI 1.28–6.87); P = 0.01

Observational data: associations, not effects.

Further findings

OutcomeP value
Intermediate- and high-risk ATA risk stratificationLow mitotic activity vs No mitotic activity · higher with low mitotic activityP < 0.001

Clinicopathologic features (vascular invasion, gross extrathyroidal extension, lymph node metastases)

Rates with low mitotic activity were in between those of no and high mitotic activity

Original publication

Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence. J Clin Endocrinol Metab. Published 30 March 2024. doi:10.1210/clinem/dgae203

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.